Revised SPC: Sandostatin (octreotide) – all presentations
SPC includes a warning for cholangitis. Cases have been reported as a complication of cholelithiasis in in the post-marketing setting. Ultrasonic examination of the gallbladder before, and at about 6- to 12-month intervals during octreotide therapy are therefore recommended.
Source:
electronic Medicines compendium